SVB Financial Group:企業の戦略・SWOT・財務情報

◆英語タイトル:SVB Financial Group - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4008
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

SVB Financial Group – Strategy, SWOT and Corporate Finance Report
Summary

SVB Financial Group – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

SVB Financial Group (SVB Financial) is a banking and financial holding company that offers commercial and private banking, asset management, and investment solutions through its principal subsidiary, Silicon Valley Bank. It provides a range of deposit services; loans and credit facilities such as equipment loans, asset-based loans, accounts-receivable-based lines of credit, term loans, credit cards, and capital call lines of credit; treasury management, investment products, private wealth management services, and foreign exchange and trade financing solutions. The company also offers non-banking solutions such as funds management, private equity investment, and venture capital through its other subsidiaries. It serves entrepreneurs, venture capital/private equity professionals, investors, corporates, enterprises of all sizes and stages, and individuals through offices in the US, China, Hong Kong, Israel, and the UK. SVB Financial is headquartered in Santa Clara, California, the US.

Scope

- Detailed information on SVB Financial Group required for business and competitor intelligence needs
- A study of the major internal and external factors affecting SVB Financial Group in the form of a SWOT analysis
- An in-depth view of the business model of SVB Financial Group including a breakdown and examination of key business segments
- Intelligence on SVB Financial Group’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about SVB Financial Group, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of SVB Financial Group and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess SVB Financial Group as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on SVB Financial Group’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
SVB Financial Group: Company Overview 9
SVB Financial Group: Overview and Key Facts 9
SVB Financial Group: Overview 9
SVB Financial Group: Key Facts 9
SVB Financial Group: Key Employees 11
SVB Financial Group: Key Employee Biographies 13
SVB Financial Group: Major Products and Services 16
SVB Financial Group: Company History 17
SVB Financial Group: Management Statement 20
SVB Financial Group: Key Competitors 24
SVB Financial Group: Company Analysis 25
SVB Financial Group: Business Description 25
SVB Financial Group: SWOT Analysis 26
SVB Financial Group: SWOT Overview 26
SVB Financial Group: Strengths 26
SVB Financial Group: Weaknesses 27
SVB Financial Group: Opportunities 27
SVB Financial Group: Threats 28
SVB Financial Group: Corporate Financial Deals Activity 30
SVB Financial Group: Financial Deals Overview 30
SVB Financial Group: Targets and Partners 32
SVB Financial Group: Top Deals 2014 – 2018YTD* 39
SVB Financial Group: Advisors 40
SVB Financial Group: Top Financial Advisors 40
SVB Financial Group: Mergers and Acquisitions 41
SVB Financial Group: Corporate Venturing 42
SVB Financial Group: Capital Raising 43
SVB Financial Group: Divestments 44
SVB Financial Group: Recent Developments 45
SVB Financial Group: News and Events Summary 45
SVB Financial Group: Business Expansion 48
SVB Financial Group: Corporate Governance 49
SVB Financial Group: Financial Deals 49
SVB Financial Group: Financial Performance 52
SVB Financial Group: Regulatory and Legal Events 52
Appendix 53
Contact Us 53
Methodology 53
About MarketLine 54

List of Tables
Table 1: SVB Financial Group: Key Facts
Table 2: SVB Financial Group: Key Employees
Table 3: SVB Financial Group: Key Competitors
Table 4: SVB Financial Group: Deal Activity by Deal Type - Volume (TTM*)
Table 5: SVB Financial Group: M&A Activity by Geography (TTM*)
Table 6: SVB Financial Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: SVB Financial Group: M&A Average Deal Size - Value (US$m)
Table 8: SVB Financial Group: Targets and Partners
Table 9: SVB Financial Group: Top Deals 2014 - 2018YTD*
Table 10: SVB Financial Group: Financial Advisor Ranking by Value (US$m)
Table 11: SVB Financial Group: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: SVB Financial Group: M&A Activity by Geography (2014 - YTD*2018)
Table 13: SVB Financial Group: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 14: SVB Financial Group: Corporate Venturing by Geography (2014 - YTD*2018)
Table 15: SVB Financial Group: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: SVB Financial Group: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: SVB Financial Group: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: SVB Financial Group: Divestments by Geography (2014 - YTD*2018)
Table 19: SVB Financial Group: News and Events Summary
Table 20: SVB Financial Group: Business Expansion
Table 21: SVB Financial Group: Corporate Governance
Table 22: SVB Financial Group: Financial Deals
Table 23: SVB Financial Group: Financial Performance
Table 24: SVB Financial Group: Regulatory and Legal Events

List of Figures
Figure 1: SVB Financial Group: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: SVB Financial Group: M&A Activity by Geography (TTM*)
Figure 3: SVB Financial Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: SVB Financial Group: M&A Average Deal Size - Value (US$m)
Figure 5: SVB Financial Group: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: SVB Financial Group: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: SVB Financial Group: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: SVB Financial Group: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: SVB Financial Group: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: SVB Financial Group: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: SVB Financial Group: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 12: SVB Financial Group: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[SVB Financial Group:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) designs and manufactures nanomedicines for the treatment of cancer. The company is evaluating its lead product candidate NBTXR3 against soft tissue sarcoma, pancreatic, liver, rectal, prostate, head and neck cancers; Non-small cell lung cancer (NSCLC); recurrent he …
  • Carna Biosciences Inc (4572):製薬・医療:M&Aディール及び事業提携情報
    Summary Carna Biosciences Inc (Carna) is a biotechnology company that discovers and develops drugs for the treatment of cancer and inflammatory diseases. The company offers products such as kinase proteins, biotinylated kinases, substrates, assay kits, protein substrates, inactive kinases, inactive- …
  • Deckers Outdoor Corporation (DECK):企業の財務・戦略的SWOT分析
    Deckers Outdoor Corporation (DECK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ascendance Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Carnarvon Petroleum Ltd (CVN):企業の財務・戦略的SWOT分析
    Summary Carnarvon Petroleum Ltd (Carnarvon Petroleum) is an oil and gas company that acquires, explores, and develops oil and gas properties. The company's projects comprise Cerberus and the Phoenix project. It has assets in Barrow sub-basin, Perth basin, and Roebuck basin. Carnarvon Petroleum's Pho …
  • Capcom Co Ltd (9697):企業の財務・戦略的SWOT分析
    Capcom Co Ltd (9697) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hanmi Pharmaceuticals Co Ltd (128940):製薬・医療:M&Aディール及び事業提携情報
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • Miromatrix Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a biotechnology company engaged in the development extracellular matrix based medical devices in soft tissue reinforcement and advanced wound care. The company offers MIRODERM a porcine liver-derived noncrosslinked acellular biologic wound matri …
  • Colby Pharmaceutical Co-製薬・医療分野:企業M&A・提携分析
    Summary Colby Pharmaceutical Company (Colby Pharma) is a biopharma company that focuses on the development of safe and effective small molecule analgesic, anti-inflammatory drug, and immunobiologic products. Its product portfolio includes Oral small molecule analgesics CPC-123 & CPC-111 for post-sur …
  • National Fuel Gas Company:企業の戦略・SWOT・財務情報
    National Fuel Gas Company - Strategy, SWOT and Corporate Finance Report Summary National Fuel Gas Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Centice Corporation-製薬・医療分野:企業M&A・提携分析
    Summary Centice Corporation (Centice) is a medical and electronic equipment company which designs, develops and offers advance sensors for various applications. The company’s products include BTL-200N, MFL-300N, BTL-200P, MFL-300P, and MFL-3000. It also provides illicit substances, prescription drug …
  • Tuesday Morning Corporation:企業の戦略・SWOT・財務情報
    Tuesday Morning Corporation - Strategy, SWOT and Corporate Finance Report Summary Tuesday Morning Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Johnson Electric Holdings Limited:企業の戦略・SWOT・財務情報
    Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Curetis NV (CURE):医療機器:M&Aディール及び事業提携情報
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue inf …
  • Forward Industries, Inc. (FORD):企業の財務・戦略的SWOT分析
    Forward Industries, Inc. (FORD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Advanced Proteome Therapeutics Corp (APC):製薬・医療:M&Aディール及び事業提携情報
    Summary Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-s …
  • R-Pharm:製薬・医療:M&Aディール及び事業提携情報
    Summary R-Pharm is a pharmaceutical company that manufactures and markets therapeutic drugs. The company offers drugs in areas of oncology, hematology, cardiology, immunology, and antibacterial and anti-viral diseases. It offers solutions on treatment of HIV-infection, organ transplantation, dissemi …
  • Schlumberger Ltd (SLB):企業の財務・戦略的SWOT分析
    Schlumberger Ltd (SLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cowen Inc:企業のM&A・事業提携・投資動向
    Cowen Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cowen Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Norwegian Energy Company ASA (NOR):企業の財務・戦略的SWOT分析
    Summary Norwegian Energy Company ASA (Noreco) is an oil and gas company that offers exploration and development services. The company explores, produces and develops oil, gas, and natural gas liquids deposit properties. It operates through ongoing and planned exploration wells such as PL616 Haribo a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆